Martina Gentile
Overview
Explore the profile of Martina Gentile including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
30
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sota J, Ragab G, AlMaglouth I, Lopalco G, Tufan A, Direskeneli H, et al.
Joint Bone Spine
. 2024 Nov;
92(2):105819.
PMID: 39549971
Objectives: Gender impact on phenotypical expression of Behçet's disease (BD) has been specifically investigated only in a few large-scale studies. The main goal of the study was to examine gender...
2.
Billi M, De Marinis E, Gentile M, Nervi C, Grignani F
Int J Mol Sci
. 2024 Jun;
25(11).
PMID: 38892257
MicroRNAs (miRNAs) are small non-coding RNAs which contribute to the regulation of many physiological and pathological processes. Conventionally, miRNAs perform their activity in the cytoplasm where they regulate gene expression...
3.
Ruscitti P, Pantano I, Cataldi G, Gentile M, Arrigoni F, Riccio L, et al.
Rheumatology (Oxford)
. 2024 Apr;
64(3):1122-1130.
PMID: 38598432
Objective: To evaluate the short-term effectiveness of guselkumab in patients with psoriatic arthritis (PsA) and suggestive features of axial involvement in a prospective 'real-life' multicentre cohort. Methods: Between June 2022...
4.
Ruscitti P, Cataldi G, Gentile M, Dionisi A, Volpe P, Finucci A, et al.
Rheumatol Ther
. 2024 Mar;
11(3):539-551.
PMID: 38436915
Introduction: Guselkumab is an interleukin-23 (IL-23) inhibitor licensed for the treatment of psoriatic arthritis (PsA). This study aimed to evaluate the 6-month effectiveness of guselkumab in patients with PsA in...
5.
DOnghia M, Cinotti E, Cartocci A, Vitale A, Caggiano V, Tognetti L, et al.
Intern Emerg Med
. 2023 Oct;
18(8):2245-2252.
PMID: 37803193
Behçet's disease (BD) is a heterogeneous multifactorial autoinflammatory disease characterized by a plethora of clinical manifestations. Cutaneous lesions are considered hallmarks of the disease. However, their evolution over time and...
6.
Ciaffi J, Ruscitti P, Di Cola I, Pavlych V, Italiano N, Gentile M, et al.
PLoS One
. 2023 Mar;
18(3):e0283283.
PMID: 36996012
Objectives: In the present study, we aimed to evaluate whole-body insulin sensitivity in systemic sclerosis (SSc) patients and to compare the results with controls with no autoimmune rheumatic disease (non-ARD)...
7.
Fucci L, Gensini L, Coppetelli U, Ortu La Barbera E, Gentile M, Fiori L, et al.
Leuk Res Rep
. 2022 Jun;
17:100330.
PMID: 35694449
We report our retrospective analysis on 34 relapsed/refractory multiple myeloma (RRMM) patients treated with daratumumab based triplets. Twenty patients were females and 14 males. Median age was 73.2. Daratumumab was...
8.
Vitale A, Della Casa F, Lopalco G, Pereira R, Ruscitti P, Giacomelli R, et al.
Front Med (Lausanne)
. 2022 Apr;
9:878797.
PMID: 35463015
Objective: Aim of this paper is to present the design, construction, and modalities of dissemination of the AutoInflammatory Disease Alliance (AIDA) International Registry for patients with systemic juvenile idiopathic arthritis...
9.
Ornello R, Colangeli E, Tommasino E, Tiseo C, Perrotta G, Scarpato C, et al.
Eur Stroke J
. 2021 Apr;
6(1):36-43.
PMID: 33817333
Background: Identifying the cause of intracerebral hemorrhage (ICH) is relevant to optimize its management. We aimed to assess the applicability and utility of the Edinburgh CT criteria for cerebral amyloid...
10.
Quattrocchi A, Maiorca C, Billi M, Tomassini S, De Marinis E, Cenfra N, et al.
Am J Hematol
. 2020 Jun;
95(10):E263-E267.
PMID: 32572989
No abstract available.